Danaher-GE BioPharma deal to be reviewed by KFTC's standing committee after investigators raise competition concerns
Danaher's takeover of GE's BioPharma business will be closely reviewed by the South Korean competition regulator’s standing committee on Jan. 22. MLex understands that case handlers of the Korea Fair Trade...To view the full article, register now.
Already a subscriber? Click here to view full article